Literature DB >> 27995419

T-cell Lymphoma Epidemiology: the Known and Unknown.

Anh Phan1, Rachel Veldman1, Mary Jo Lechowicz2.   

Abstract

T-cell lymphoma, a collection of subtypes of Non-Hodgkin lymphoma, is a rare malignancy. The low prevalence of this disease has made it challenging to identify subtype-specific risk factors. Potential risk factors could enable us to identify high-risk patients and predict patient outcomes. Here, we report on the current epidemiologic and prognostic factors data associated with the individual subtypes both of peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) found in large cohort and case studies. Additionally, with recent findings, as well as updates in the new World Health Organization (WHO) classification of lymphoid neoplasms, we consider what this could do to change our approach to this group of diseases.

Entities:  

Keywords:  Cutaneous T-cell lymphoma; Epidemiology; Peripheral T-cell lymphoma; T-cell lymphoma

Mesh:

Year:  2016        PMID: 27995419     DOI: 10.1007/s11899-016-0353-y

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  103 in total

1.  Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.

Authors:  Elizabeth K Cahoon; Ruth M Pfeiffer; David C Wheeler; Juan Arhancet; Shih-Wen Lin; Bruce H Alexander; Martha S Linet; D Michal Freedman
Journal:  Int J Cancer       Date:  2014-10-13       Impact factor: 7.396

2.  Epstein-Barr virus in angioimmunoblastic T-cell lymphomas.

Authors:  G Khan; A J Norton; G Slavin
Journal:  Histopathology       Date:  1993-02       Impact factor: 5.087

3.  Changing incidence trends of cutaneous T-cell lymphoma.

Authors:  Kaveri Korgavkar; Michael Xiong; Martin Weinstock
Journal:  JAMA Dermatol       Date:  2013-11       Impact factor: 10.282

4.  Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991-2006.

Authors:  Qasem A Alsaleh; Arti Nanda; Hejab Al-Ajmi; Homoud Al-Sabah; Muhammad Elkashlan; Salem Al-Shemmari; Marie-France Demierre
Journal:  Int J Dermatol       Date:  2010-12       Impact factor: 2.736

Review 5.  Cutaneous lymphomas: an update. Part 1: T-cell and natural killer/t-cell lymphomas and related conditions.

Authors:  Werner Kempf; Dmitry V Kazakov; Katrin Kerl
Journal:  Am J Dermatopathol       Date:  2014-02       Impact factor: 1.533

6.  A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.

Authors:  Janet Y Li; Melissa P Pulitzer; Patricia L Myskowski; Stephen W Dusza; Steven Horwitz; Alison Moskowitz; Christiane Querfeld
Journal:  J Am Acad Dermatol       Date:  2013-05-16       Impact factor: 11.527

7.  A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.

Authors:  E C Benton; S Crichton; R Talpur; N S Agar; P A Fields; E Wedgeworth; T J Mitchell; M Cox; S Ferreira; P Liu; A Robson; E Calonje; C M Stefanato; B Wilkins; J Scarisbrick; E M Wain; F Child; S Morris; M Duvic; S J Whittaker
Journal:  Eur J Cancer       Date:  2013-06-01       Impact factor: 9.162

8.  Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.

Authors:  Emmilia Hodak; Iris Amitay-Laish; Meora Feinmesser; Batya Davidovici; Michael David; Alex Zvulunov; Felix Pavlotsky; Isaac Yaniv; Gali Avrahami; Dan Ben-Amitai
Journal:  J Am Acad Dermatol       Date:  2014-03-12       Impact factor: 11.527

9.  Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.

Authors:  Vincent D Criscione; Martin A Weinstock
Journal:  Arch Dermatol       Date:  2007-07

10.  Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.

Authors:  A Smith; S Crouch; S Lax; J Li; D Painter; D Howell; R Patmore; A Jack; E Roman
Journal:  Br J Cancer       Date:  2015-03-24       Impact factor: 7.640

View more
  11 in total

1.  Correlation between the prevalence of T-cell lymphomas and alcohol consumption.

Authors:  Minodora Desmirean; Cedric Richlitzki; Sergiu Pasca; Patric Teodorescu; Bobe Petrushev; Sebastian Rauch; Jacob Steinheber; Sabina Iluta; Jiaxin Liu; Delia Dima; Ravnit Grewal; Weina Ma; Liren Qian; Ciprian Tomuleasa
Journal:  Med Pharm Rep       Date:  2021-07-29

2.  Immunohistochemical evaluation and prognostic value of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in T-cell non-Hodgkin lymphoma.

Authors:  Hu Zhao; Yuan Chen; You-Ping Liao; Hai-Mei Chen; Qiu-Hong Yang; Yin Xiao; Jing Luo; Zhen-Zhen Chen; Lai Yi; Guo-Yu Hu
Journal:  Clin Exp Med       Date:  2022-03-03       Impact factor: 3.984

3.  NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice.

Authors:  Sigrid Dubois; Lionel Feigenbaum; Thomas A Waldmann; Jürgen R Müller
Journal:  Cell Immunol       Date:  2020-02-27       Impact factor: 4.868

Review 4.  Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas.

Authors:  Alexander Neuwelt; Taha Al-Juhaishi; Eduardo Davila; Bradley Haverkos
Journal:  Blood Adv       Date:  2020-09-08

5.  Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.

Authors:  Megan J Fitzpatrick; Shahin Sayed; Zahir Moloo; Mukendi K A Kayembe; Drucilla J Roberts; Thu-Anh Pham; Liqiang Xi; Mark Raffeld; Abner Louissaint; Aliyah R Sohani
Journal:  Am J Clin Pathol       Date:  2021-06-17       Impact factor: 2.493

6.  E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study.

Authors:  Ken Ohmachi; Kiyoshi Ando; Michinori Ogura; Toshiki Uchida; Kensei Tobinai; Dai Maruyama; Masayuki Namiki; Tadashi Nakanishi
Journal:  Cancer Sci       Date:  2018-02-26       Impact factor: 6.716

Review 7.  Updating targets for natural killer/T-cell lymphoma immunotherapy.

Authors:  Weili Xue; Mingzhi Zhang
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

8.  A weakly supervised deep learning approach for label-free imaging flow-cytometry-based blood diagnostics.

Authors:  Corin F Otesteanu; Martina Ugrinic; Gregor Holzner; Yun-Tsan Chang; Christina Fassnacht; Emmanuella Guenova; Stavros Stavrakis; Andrew deMello; Manfred Claassen
Journal:  Cell Rep Methods       Date:  2021-10-25

Review 9.  Quercetin as a Novel Therapeutic Approach for Lymphoma.

Authors:  Saiedeh Razi Soofiyani; Kamran Hosseini; Haleh Forouhandeh; Tohid Ghasemnejad; Vahideh Tarhriz; Parina Asgharian; Željko Reiner; Javad Sharifi-Rad; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-08-02       Impact factor: 6.543

Review 10.  The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications.

Authors:  Adelaide Ohui Fierti; Michael Bright Yakass; Ernest Adjei Okertchiri; Samuel Mawuli Adadey; Osbourne Quaye
Journal:  Biomolecules       Date:  2022-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.